PHS
PRAX icon

PFM Health Sciences’s Praxis Precision Medicines PRAX Stock Holding History

PFM Health Sciences’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.4M Buy
35,438
+4,275
+14% +$1.32M 1.04% 33
2025
Q4 		$9.18M Sell
31,163
-29,415
-49% -$5.48M 0.92% 33
2025
Q3 		$3.21M Sell
60,578
-24,135
-28% -$1.17M 0.25% 60
2025
Q2 		$3.56M Sell
84,713
-76,153
-47% -$2.9M 0.3% 45
2025
Q1 		$6.09M Buy
160,866
+41,357
+35% +$2.58M 0.44% 41
2024
Q4 		$9.2M Sell
119,509
-63,583
-35% -$4.6M 0.57% 44
2024
Q3 		$10.5M Sell
183,092
-270,054
-60% -$14.6M 0.6% 39
2024
Q2 		$18.7M Sell
453,146
-24,459
-5% -$1.16M 0.93% 35
2024
Q1 		$29.1M Sell
477,605
-178,943
-27% -$8.03M 1.37% 26
2023
Q4 		$14.6M Buy
656,548
+61,882
+10% +$1.11M 0.88% 37
2023
Q3 		$15.3M Buy
594,666
+1,882
+0.3% +$35.6K 0.72% 45
2023
Q2 		$10.2M Buy
592,784
+447,678
+309% +$6.85M 0.4% 60
2023
Q1 		$1.76M Sell
145,106
-40,058
-22% -$1.69M 0.08% 73
2022
Q4 		$6.61M Sell
185,164
-45,404
-20% -$1.42M 0.24% 72
2022
Q3 		$7.85M Buy
230,568
+10,745
+5% +$535K 0.28% 69
2022
Q2 		$8.08M Buy
219,823
+162,168
+281% +$17.3M 0.31% 64
2022
Q1 		$8.83M Buy
57,655
+15,261
+36% +$3.13M 0.33% 56
2021
Q4 		$12.5M Buy
42,394
+12,036
+40% +$3.53M 0.43% 53
2021
Q3 		$8.42M Hold
30,358
– – 0.25% 66
2021
Q2 		$8.32M Buy
+30,358
New +$10.9M 0.26% 67

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

PFM Health Sciences's PRAX Position: Q1 2026 in Review

PFM Health Sciences increased its Praxis Precision Medicines (PRAX) stake by 14% in Q1 2026, buying an estimated $1.32M and bringing the position to 35,438 shares worth $11.4M. The position accounts for 1.04% of the portfolio, ranked #33.

PFM Health Sciences first reported a position in PRAX in Q2 2021 and has held it in 20 quarters since. The position peaked at $29.1M in Q1 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • PFM Health Sciences held 35,438 shares of Praxis Precision Medicines worth $11.4M as of Q1 2026.
  • PFM Health Sciences bought 4,275 Praxis Precision Medicines shares in Q1 2026, an estimated $1.32M.
  • Praxis Precision Medicines made up 1.04% of PFM Health Sciences's portfolio in Q1 2026, its #33 holding.
  • PFM Health Sciences first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 20 quarters since.
  • PFM Health Sciences's Praxis Precision Medicines position peaked at $29.1M in Q1 2024.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.